FTC clears Elanco to acquire Bayer Animal Health
The Federal Trade Commission has approved the acquisition of Bayer Animal Health by Elanco Animal Health.
The FTC approval is contingent upon Elanco divesting several of its products.
Elanco has also received antitrust clearance from the necessary countries and the European Commission.
The deal is expected to close early next month. Bayer had to divest of its animal health division in its acquisition of Monsanto.